This course is designed to improve the knowledge and understanding of medicolegal aspects of concussion.  Athletic trainers in all settings who work with athletes suffering from concussions should have a thorough understanding of the medicolegal aspects of these cases.  Understanding the current landscape of concussion legislation, knowing how to analyze best practice guidelines, and how to incorporate concussion management protocols into practice are proactive ways the practicing athletic trainer can work to mitigate the risk of litigation.  This presentation will cover these topics with the following objectives:

The specific objectives for this course include the development of the participant’s ability to:

1. Describe the current landscape of concussion legislation
2. Discuss basic legal terminology
3. Analyze the importance of best practice guidelines in concussion management to prevent potential litigation
4. Incorporate current concussion management protocols into medical practice to prevent potential litigation
5. Review current litigation trends

According to the education levels described by the PDC, this continuing education course is considered to be Essential Level, and is appropriate for all athletic trainers.

(1.25 Category A CEUs – FREE)

This course is designed to improve the knowledge and understanding of medicolegal aspects of concussion.  Athletic trainers in all settings who work with athletes suffering from concussions should have a thorough understanding of the medicolegal aspects of these cases.  Understanding the current landscape of concussion legislation, knowing how to analyze best practice guidelines, and how to incorporate concussion management protocols into practice are proactive ways the practicing athletic trainer can work to mitigate the risk of litigation.  This presentation will cover these topics with the following objectives:

The specific objectives for this course include the development of the participant’s ability to:

1. Describe the current landscape of concussion legislation
2. Discuss basic legal terminology
3. Analyze the importance of best practice guidelines in concussion management to prevent potential litigation
4. Incorporate current concussion management protocols into medical practice to prevent potential litigation
5. Review current litigation trends

According to the education levels described by the PDC, this continuing education course is considered to be Essential Level, and is appropriate for all athletic trainers.

(1.25 Category A CEUs – FREE)

Course Instructors:

Tamara McLeod, PhD, ATC, FNATA

Although many athletic trainers use clinical practice guidelines, position statements, and consensus statements to identify best practices for the management of various illnesses and injuries, fewer understand the differences between these types of documents and the development process for these documents. This course aims to differentiate between clinical practice guidelines, position statements, and consensus statements and describe the process of how these documents are develop. Using the published documents regarding sport-related concussion, examples between the similarities and differences in recommendations made among these documents will be illustrated. Specifically, focus will be on similarities and differences in diagnosis, prevention, assessment, management, and the use of neurocognitive testing. A discussion of the historical changes in recommendations from Vienna and the 2004 NATA statement through the 2014 NATA statement and the recently released Berlin consensus statement will also be included.

This course aims to cover the following objectives, which will be presented in four individual online modules:  

1. Describe the development process for clinical practice guidelines
2. Differentiate between types of clinical practice guidelines
3. Discuss the process used to develop the Berlin concussion consensus statement
4. Identify best practices according to the Berlin concussion consensus statement
5. Compare recommendations from various statements and guidelines for use in clinical practice

According to the education levels described by the PDC, this continuing education course is considered to be Advanced Level, and is appropriate for all athletic trainers.

Course Instructor:
Sue Falsone, PT, MS, SCS, ATC, CSCS, COMT, RYT

Although most athletic trainers deal with patients who are in pain, very few clinicians understand the complexity of pain perception and the individuality by which it presents itself from patient to patient.  Often, patients of the same gender, around the same age, with the same diagnosis, present very differently when it comes to the amount of pain they are experiencing.  This presents a difficult scenario for the athletic trainer, who may be utilizing past clinical experience to manage a current patient.  Truly understanding the biopsychosocial aspects of pain and understanding the most recent literature on pain sciences will be helpful to the clinical athletic trainer, who is often tasked with helping a patient simply “feel better”.   Pain affects movement, so athletic trainers who are attempting to change an athletes’ movement patterns first must address the pain perception that can be altering the movement patterns.  Proper modality selection and counseling is a must in order for the athletic trainer to be effective  in the field of pain management.

Pain is a multifactorial experience and should be addressed via a comprehensive biopsychosocial intervention model.  Pain and nociceptive stimulation do not go hand in hand, meaning pain can be present in the absence of nociceptive stimulation. Therefore, the clinician needs to understand not only the physical neurology of the sensation of pain, but the emotional, psychological, social, and personal experiences that factor into the creation of pain perception.  With this comprehensive understanding, the clinician should be able to select an appropriate intervention to modulate pain based on the needs of the individual patient

This course aims to cover the following objectives, which will be presented in five individual online modules:

1. Appreciate that pain is a multi-factorial experience, and should be treated via a multi-factorial approach including physical, emotional and biopsychosocial considerations
2. Identify different pain theories and the basic neurology underlying the sensation of pain
3. Understand how pain may affect normal movement patterns
4. Implement different modalities to address pain and improve movement
5. Understand the effects of different modalities on pain modulation and describe the mechanism of action for these modalities

Association for Continuing Dental Education Joint Provider Live Webinar Series

Partial Root Extraction Therapy (PET): A Tactic to Rescue Buccal Plate

Date:                    Wednesday, December 1, 2021

Time:                    7:00 PM CST, 8 PM EST, 5 PM PST

Location:              Zoom

Audience:            The Dental Professional

Format:                Lecture

CE Credit:             2.0 credits

Tuition:                 $69

Description:

Bone loss around extraction sites is due to the destruction of the periodontal ligament to bone complex. This is problematic in aesthetic areas, specifically the anterior maxilla. Many procedures and materials have been used to regain or cover lost bone structure (such as bone and gingival grafts). These can be costly and time consuming to patients. Research has shown great potential in partial extraction therapies (PET) where part of the natural tooth root is purposely left attached to the buccal plate of bone to prevent its loss. These therapies are more conservative than normal extractions and require no additional materials. This presentation aims at shedding more light on this technique as well its contraindications and limitations.

Learning Outcomes:

At the conclusion of this course, participants will be able to:

• Review the hard and soft-tissue effects of tooth loss.
• Review the different treatment options for tooth loss and the advantages/ disadvantages of each.
• Review some of the new techniques recommended to mitigate the effects of hard and soft-tissue loss, especially in the aesthetic zone.
• Provide a clear understanding and definition of “Partial Root Extraction Therapy – PET”.
• Review some of the cases treated utilizing PET techniques.
• Review the different contraindications and limitations for using PET.

Meet the Speaker:

Nader Hamdan, B.D.S., M.Sc., M.Dent, FRCD(C)

Dr. Nader Hamdan is currently an Assistant Professor and Director of the Graduate Periodontics Program, Faculty of Dentistry at Dalhousie University. Dr. Hamdan received a Bachelor of Dental Surgery (B.D.S.) from Jordan University of Science and Technology (Jordan), then a Master of Science (MSc) in Dental Sciences from McGill University (Canada), and a Master of Dentistry in Periodontics (M.Dent.) as well as residency training in periodontics from the University of Manitoba (Canada). Dr. Hamdan is a Fellow of the Royal College of Dentists of Canada (Canada), a Diplomate of the American Board of Periodontology and Dental Implant Surgery (USA), and a Fellow of the Faculty of Dental Surgery of the Royal College of Physicians and Surgeons of Glasgow (UK).  Dr. Hamdan was invited to speak, lecture and give continuous dental education courses nationally and internationally and has many published scientific articles. Dr. Hamdan was also invited to co-author multiple book chapters and books in the fields of dental Implantology and periodontics and he is a reviewer for multiple peer-reviewed international dental journals. Dr. Hamdan holds many memberships in national and international professional organizations. Besides his academic full-time position, Dr. Hamdan treats his own patients in multiple private practices limited to periodontics and Dental Implant Surgery in Canada.

REGISTER BELOW UNDER “CHOOSE TUITION TYPE”

FOR MORE COURSE INFORMATION CLICK HERE

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

A.T. Still University Missouri School of Dentistry & Oral Health

Nationally Approved PACE Program

Provider for FAGD/MAGD credit.

Approval does not imply acceptance by

Any regulatory authority or AGD endorsement.

5/1/2020 to 4/30/2022.

Provider ID# 397632

Dermatology Hands-on Workshop

Dec. 2, 2021| 8:00 a.m. – 11:00 a.m.

REGISTRATION HAS CLOSED

Click MORE for program information and tuition pricing.

CLICK HERE for information on our 2021 Big Cedar Primary Care Update: Challenges of Care

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Primary Care Update: Challenges of Care

Dec. 2-4, 2021

REGISTRATION HAS CLOSED

Click MORE for program information and tuition pricing.

CLICK HERE for information on our 2021 Big Cedar Pre-Conference: Dermatology Hands-on Workshop

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any p is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call

Association for Continuing Dental Education Joint Provider Live Webinar Series

Educating the Dental Team on Nutritional Counseling for the Patient: From Birth through the Life Cycle

Date:                      Sunday, December 5, 2021

Time:                      2:30 PM CST, 3:30 PM EST, 12:30 PM PST

Location:               Zoom

Audience:              The Dental Professional

Format:                 Lecture

CE Credit:              2.0 credits

Tuition:                  $69

Course Description:

This presentation will discuss the definition of nutrition as well as distinguish between evidence-based ideas and nutritional myths.  The critical role of scientific evidence-based dietary and nutritional counseling for patients across the entire life span- starting with the pregnant mother and moving through infancy, early childhood, elementary and middle school years, adolescence, adulthood and finally geriatric years will be discussed.  Well-balanced nutrition is critical in prevention of most chronic diseases as well as in wound healing. The dental team, consisting of the dentist, dental hygienist, dental assistant and including the front desk staff must all fully understand the critical role of diet and nutrition in oral and systemic health and engage in the process of dietary and nutritional counseling for all patients.  It is imperative that scientific evidence be considered and widespread myths about nutrition and their effects understood clearly by dental professionals.

Learning Objectives:

At the conclusion of this course, participants will be able to:

• Discuss a clear definition of Nutrition
• Clarify and distinguish between evidence-based ideas and nutritional myths
• Understand the importance of involving the entire dental team in dietary and nutritional counseling for patients across the human life-span
• Describe Dietary Guidelines for all Americans
• Discuss dietary counseling for patients with active caries, periodontal disease, halitosis as well as overweight, obesity, T2 Diabetes, hypertension, cardiovascular conditions, etc.
• Describe dietary advice for patients on soft diets, mechanically pureed diets, those undergoing oral surgery, and denture fabrication

Meet the Speaker:

 Poonam Jain, B.D.S., M.S, M.P.H.

Dr. Poonam Jain is the Vice Dean for Clinical Affairs and Advanced Dental Education at the Missouri School of Dentistry and Oral Health – A.T. Still University.  She has an M.P.H. from St. Louis University and an M.S. and Certificate in Operative Dentistry from The University of Iowa.  She graduated with a B.D.S. degree from the University of Delhi, New Delhi, India. In addition to her current administrative role as Vice Dean, Dr. Jain has extensive experience teaching and directing didactic, pre-clinical, and clinical courses for pre-doctoral students in operative dentistry, dental materials, dental morphology, cariology, community, and preventive dentistry, special needs, and geriatric dentistry.  She has engaged in numerous research projects and published several research articles as well as abstracts.  Dr. Jain has been very active in mentoring students in research as well.  She also owns a successful private practice in Staunton, Illinois. Dr. Jain has been very active in numerous community service projects and has been the organizer for several Give Kids a Smile, National Children’s Dental Health Month as well as Special Olympics events.  She is a fellow of the International as well as American College of Dentists and serves on the Board of the National CAMBRA Coalition.

REGISTER BELOW UNDER “CHOOSE TUITION TYPE”

FOR MORE INFORMATION CLICK HERE

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

A.T. Still University Missouri School of Dentistry & Oral Health

Nationally Approved PACE Program

Provider for FAGD/MAGD credit.

Approval does not imply acceptance by

Any regulatory authority or AGD endorsement.

5/1/2020 to 4/30/2022.

Provider ID# 397632